Patient with her doctor

Premier Members

AI-powered mammography vendor-of-choice

Smarter Breast AI via Premier Access

It’s About Time to deliver faster, more precise breast cancer detection — now with exclusive Premier member pricing and seamless onboarding for the ProFound Breast Health Suite.

Every patient’s breast health journey deserves trust, clarity, and speed. That’s why we’re proud to announce a national group purchasing agreement with Premier, Inc., making it easier than ever for Premier members to access the ProFound Breast Health Suite.

Take advantage of seamless onboarding — empowering you to deliver smarter breast AI that reduces diagnostic uncertainty, accelerates decision-making, and supports personalized patient care.

Download Brochures

Let’s Connect

New FDA Cleared ProFound Detection V4.0

Smarter Breast AI: Focus on the lesions that matter most.

Introducing iCAD’s Smarter Breast AI Platform.

ProFound AI Breast Health Suite

Powered by the latest innovations in artificial intelligence (AI), the ProFound AI Suite offers clinically proven cancer detection and standardized density assessment solutions. Discover its unrivaled accuracy, as well as multi‐vendor compatibility and unique workflow advantages.

Share your experience.
This field is for validation purposes and should be left unchanged.

ProFound Detection and Density solutions provide the accuracy and precision you need in an AI solution to help find breast cancer earlier.

The ProFound Scorecard displays insights at a glance, indicating the overall level of suspicion of the case and density score in one place.

V4 with Prior

Clinical Results: Premier Member at Baptist Health

Dr. Kathy Schilling, Boca Raton Regional Hospital

Their deployment of ProFound AI helped her team of 9 breast trained radiologists:

  • Increase CDR by +23% without increasing recall rates1
  • Improve detection of invasive lobular cancers by 2x2
  • Reduce cancer size at diagnosis by -12%2
  • Increase cancers detected in Dense breasts by +32%2
  • Decrease Histopathic Stage by -40% T2’s2
  • Maintained Recall Rate and Number of DCIS2

ProFound Interoperability.

Flexible deployment with unmatched speed, scalability, and security.

ProFound Cloud

ProFound Cloud

Platform

Your
Platform

ProFound On Premises

ProFound
On-Premises

50+ PACS & 94 versions | 2D & 3D OEM manufacturers | AI platform providers & workflow systems

We work the way you want to work.

Rapid implementation for a swift go-live.

Flexible & secure deployment options for smooth IT adoption.

Seamless integration within your workflow and systems you trust.

Let’s Connect

We look forward to meeting with you.

Schedule a time to connect with us live or virtually to discuss how iCAD’s ProFound AI Breast Health Suite of solutions can best support your current workflow needs.

1. Schilling K. et al. Real-world breast cancer screening performance with digital breast tomosynthesis before and after implementation of an artificial intelligence detection system. Presented at the European Congress of Radiology (ECR), March 1-5, 2023 in Vienna, Austria. 2. Schilling K. et al. Real World Effect of Artificial Intelligence on Histopathology and Stage in Breast Cancer Screening with Digital Breast Tomosynthesis. Presented at the Radiology Society of North America (RSNA), December 1-5, 2024 in Chicago, IL.